CheckMyRecalls

Hikma Pharmaceuticals USA INC. recalls

5 recall notices naming Hikma Pharmaceuticals USA INC. since January 2025, in United States. The most recent was published 11 Nov 2026.

Latest recalls (5)

  1. Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin TabletsFDACGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
  2. Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USPFDAFailed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
  3. Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USPFDAFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
  4. Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral SolutionFDAThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
  5. Hikma Pharmaceuticals USA Inc. recalls Lorazepam InjectionFDAFailed Impurities/Degradation Specifications: An out-of-Specification for total related compounds